StemCell Therapy

(PRWEB UK) 22 September 2014

BioKidz is a simple concept which aims to engage children in the importance of stem cell medicine. Aimed at an audience of 4-9 year olds, the company now aims to use it in the 21 countries in which it operates.

BioEden has been invited to speak with parents and teachers later this month, as the BioKidz site aims to be a good source of scientific information for primary school teachers.

The BioEden proposition is very simple one: harvest the stem cells from a naturally shed baby tooth, store the viable cells for future therapeutic use, and guarantee that the cells will be available when needed.

As stem cell medicine is now becoming commonplace, it is important that there is a stem cell match when needed. The easiest way to do this is by harvesting and storing one's own cells, and there is no easier way than from naturally shed teeth.

The company admits that they could be putting the ordinary tooth fairy out of business, but they hasten to add that BioKidz have their own hero in the form of a Super Tooth Fairy who works within their own stem cell laboratories.

Children can meet BioEden the Super Tooth Fairy by visiting http://www.bioeden.com.

Read this article:
BioKidz: the Children of the Stem Cell Revolution to go Global

Daniel Kraft Interview - Singularity University - C100 CEO Summit
Daniel Kraft shows off his mini-me and talks about 3d printing organs and other body parts using stem cells with Daniel Kraft at Rosewood Sand Hill.

By: kris krg

Continued here:
Daniel Kraft Interview - Singularity University - C100 CEO Summit - Video

Will This New Stem Cell Treatment End The Controversy?
Embryonic stem cells are pluripotent, meaning they can become almost any type of cell. Since stem cell research is so controversial, researchers might have found a more ethical way to use stem...

By: DNews

Read more from the original source:
Will This New Stem Cell Treatment End The Controversy? - Video

Inflammatory Bowel Disease (IBD) Stem Cell Research: Ophir Klein, UCSF

By: California Institute for Regenerative Medicine

See the original post here:
Inflammatory Bowel Disease (IBD) & Stem Cell Research: Ophir Klein, UCSF - Video

Pevonia Stem Cells Phyto-Elite Line Review + Giveaway
Head over to BeingZhenya.com to enter for a chance to win one of 5 sample kits. #PevoniaLife Disclosure: This video was created in partnership with Pevonia. ...

By: BeingZhenya

Read more here:
Pevonia Stem Cells Phyto-Elite Line Review + Giveaway - Video

A Trojan horse in the fight against cancer | Marina Cihova | TEDxBratislava
This talk was given at a local TEDx event, produced independently of the TED Conferences. Marna Cihov presents her fascinating research of the therapeutic potential of stem cells in cancer...

By: TEDx Talks

Read the original here:
A Trojan horse in the fight against cancer | Marina Cihova | TEDxBratislava - Video

Fibroblast Growth Factor FGF Stem Cells 360p
to order your Laminine Pls txt/call Ronald Torrefiel +63 932 919 3383 Phils.

By: Ronald Torrefiel

Read more:
Fibroblast Growth Factor FGF & Stem Cells 360p - Video

Stem Cell Therapy Professional Football Player
James Lee a Professional Football player is back in action thanks to stem cell therapy and Dr. Dennis M. Lox MD. Dr. Lox | http://www.drloxstemcells.com | (844) 440-8503.

By: Dr. Lox

Read more:
Stem Cell Therapy Professional Football Player - Video

9 Global Options Stem Cell Therapy for Parkinson #39;s Disease
Parkinson #39;s disease is a neuromuscular condition that affects millions of people around the world. Uncontrollable movement of the body muscles along with strong shaking and trembling of extremiti...

By: placidways

Read more here:
9 Global Options Stem Cell Therapy for Parkinson's Disease - Video

Cellular therapeutics -- using intact cells to treat and cure disease -- is a hugely promising new approach in medicine but it is hindered by the inability of doctors and scientists to effectively track the movements, destination and persistence of these cells in patients without resorting to invasive procedures, like tissue sampling.

In a paper published September 17 in the online journal Magnetic Resonance in Medicine, researchers at the University of California, San Diego School of Medicine, University of Pittsburgh and elsewhere describe the first human tests of using a perfluorocarbon (PFC) tracer in combination with non-invasive magnetic resonance imaging (MRI) to track therapeutic immune cells injected into patients with colorectal cancer.

"Initially, we see this technique used for clinical trials that involve tests of new cell therapies," said first author Eric T. Ahrens, PhD, professor in the Department of Radiology at UC San Diego. "Clinical development of cell therapies can be accelerated by providing feedback regarding cell motility, optimal delivery routes, individual therapeutic doses and engraftment success."

Currently, there is no accepted way to image cells in the human body that covers a broad range of cell types and diseases. Earlier techniques have used metal ion-based vascular MRI contrast agents and radioisotopes. The former have proven difficult to differentiate in vivo; the latter raise concerns about radiation toxicity and do not provide the anatomical detail available with MRIs.

"This is the first human PFC cell tracking agent, which is a new way to do MRI cell tracking," said Ahrens. "It's the first example of a clinical MRI agent designed specifically for cell tracking."

Researchers used a PFC tracer agent and an MRI technique that directly detects fluorine atoms in labeled cells. Fluorine atoms naturally occur in extremely low concentrations in the body, making it easier to observe cells labeled with fluorine using MRI. In this case, the modified and labeled dendritic cells -- potent stimulators of the immune system -- were first prepared from white blood cells extracted from the patient. The cells were then injected into patients with stage 4 metastatic colorectal cancer to stimulate an anti-cancer T-cell immune response.

The published study did not assess the efficacy of the cell therapy, but rather the ability of researchers to detect the labeled cells and monitor what happened to them. Ahrens said the technique worked as expected, with the surprising finding that only half of the delivered cell vaccine remained at the inoculation site after 24 hours.

"The imaging agent technology has been to shown to be able to tag any cell type that is of interest," Ahrens said. "It is a platform imaging technology for a wide range of diseases and applications," which might also speed development of relevant therapies.

"Non-invasive cell tracking may help lower regulatory barriers," Ahrens explained. "For example, new stem cell therapies can be slow to obtain regulatory approvals in part because it is difficult, if not impossible, with current approaches to verify survival and location of transplanted cells. And cell therapy trials generally have a high cost per patient. Tools that allow the investigator to gain a 'richer' data set from individual patients mean it may be possible to reduce patient numbers enrolled in a trial, thus reducing total trial cost."

Story Source:

Visit link:
Better way to track emerging cell therapies using MRIs

Edgar Irastorza was just 31 when his heart stopped beating in October 2008.

A Miami property manager, Irastorza had recently gained weight as his wife's third pregnancy progressed. "I kind of got pregnant, too," he said.

During a workout one day, he felt short of breath and insisted that friends rush him to the hospital. Minutes later, his pulse flatlined. He survived the heart attack, but the scar tissue that resulted cut his heart's pumping ability by a third. He couldn't pick up his children. He fell asleep every night wondering if he would wake up in the morning.

Desperation motivated Irastorza to volunteer for a highly unusual medical research trial: getting stem cells injected directly into his heart. "I just trusted my doctors and the science behind it, and said, 'This is my only chance,' " he said recently.

Over the last five years, by studying stem cells in lab dishes, test animals and intrepid patients like Irastorza, researchers have brought the vague, grandiose promises of stem cell therapies closer to reality.

Stem cells broke into the public consciousness in the early 1990s, alluring for their potential to help the body beat back diseases of degeneration like Alzheimer's, and to grow new parts to treat conditions like spinal cord injuries.

Progress has been slow. But researchers are learning how to best use stem cells, what types to use and how to deliver them to the body findings that are not singularly transformational, but progressive and pragmatic.

As many as 4,500 clinical trials involving stem cells are under way in the United States to treat patients with heart disease, blindness, Parkinson's, HIV, blood cancers and spinal cord injuries, among other conditions.

Initial studies suggest that stem cell therapy can be delivered safely, said Dr. Ellen Feigal, senior vice president of research and development at the California Institute of Regenerative Medicine, the state stem cell agency, which has awarded more than $2 billion toward stem cell research since 2006.

But enthusiasm for stem cells sometimes outstrips the science. When Gov. Rick Perry of Texas had adult stem cells injected into his spine in 2011 for a back injury, his surgeon had never tried the procedure and had no data to support the experiment. A June review in the New England Journal of Medicine found that "platelet-rich plasma" stem cell therapies praised by a number of athletes worked no better than placebos.

Read the original here:
Stem cell revolution gets closer

Stem Cell Therapy | why no more news about embryonic stem cells
http://www.arthritistreatmentcenter.com Is embryonic stem cell research passe? Next How come no more news about embryonic stem cells? Embryonic stem cells come from human embryos and these...

By: Nathan Wei

Read the rest here:
Stem Cell Therapy | why no more news about embryonic stem cells - Video

PUBLIC RELEASE DATE:

18-Sep-2014

Contact: Louise Walsh louise.walsh@admin.cam.ac.uk 44-012-237-65443 University of Cambridge @Cambridge_Uni

Stem cells hold great promise as a means of repairing cells in conditions such as multiple sclerosis, stroke or injuries of the spinal cord because they have the ability to develop into almost any cell type. Now, new research shows that stem cell therapy can also work through a mechanism other than cell replacement.

In a study published today in Molecular Cell, a team of researchers led by the University of Cambridge has shown that stem cells "communicate" with cells by transferring molecules via fluid filled bags called vesicles, helping other cells to modify the damaging immune response around them.

Although scientists have speculated that stem cells might act rather like drugs in sensing signals, moving to specific areas of the body and executing complex reactions this is the first time that a molecular mechanism for this process has been demonstrated. By understanding this process better, researchers can identify ways of maximising the efficiency of stem-cell-based therapies.

Dr Stefano Pluchino from the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, who led the study, said: "These tiny vesicles in stem cells contain molecules like proteins and nucleic acids that stimulate the target cells and help them to survive they act like mini "first aid kits".

"Essentially, they mirror how the stem cells respond to an inflammatory environment like that seen during complex neural injuries and diseases, and they pass this ability on to the target cells. We think this helps injured brain cells to repair themselves."

Mice with damage to brain cells such as the damage seen in multiple sclerosis show a remarkable level of recovery when neural stem/precursor cells (NPCs) are injected into their circulatory system. It has been suggested that this happens because the NPCs discharge molecules that regulate the immune system and that ultimately reduce tissue damage or enhance tissue repair.

The team of researchers from the UK, Australia, Italy, China and Spain has now shown that NPCs make vesicles when they are in the vicinity of an immune response, and especially in response to a small protein, or cytokine, called Interferon-gamma which is released by immune cells. This protein has the ability to regulate both the immune responses and intrinsic brain repair programmes and can alter the function of cells by regulating the activity of scores of genes.

More here:
Stem cells use 'first aid kits' to repair damage

Autologous Retrodifferentiated Neuronal stem cells therapy for Cerebral Palsy
cerebral palsy child treated with autologous retrodifferentiated neuronal stem cells and followed over time to see progress of therap ...

By: Ilham Abuljadayel

Read more:
Autologous Retrodifferentiated Neuronal stem cells therapy for Cerebral Palsy - Video

Blazin #39; For Rikky 2014
A kid that was told he would never walk, and with the miracle of stem cells he just may get that chance! When we were 20 weeks pregnant and the Spina Bifida was seen on the ultrasound, our...

By: Heath Reese

Read more:
Blazin' For Rikky 2014 - Video

Kickstarter Promo Update Sept 15 2014 - Stem Cell Treatment for Hope, Love and Freedom
Hello my name is Sonny, I was born with a nerve disease, a genetic mutation that causes the muscles in my arms, hands, legs and feet to atrophy and to become weak. I now have perfect legs....for...

By: Sonny Davis

See the rest here:
Kickstarter Promo Update Sept 15 2014 - Stem Cell Treatment for Hope, Love and Freedom - Video

ABC Ralph Bright harvests stem cells using the liposuction.

Serious questions have been raised about a stem cell doctor working in Western Sydney who charges $9,000 per procedure and uses methods that are untested by clinical trials.

An investigation by the ABC's 7.30 program has revealed that Dr Ralph Bright bought his liposuction-based technology from an American company.

The US company is now the subject of a multi-million dollar fraud action, which has revealed the cells being marketed as live were in fact dead.

Dr Bright, of Macquarie Stem Cells, is a former GP and self-taught cosmetic surgeon.

He has been working with stem cells for four years, treating more than 400 patients, including the late model Charlotte Dawson, cricketer Geoff Lawson and Olympic volleyballer Kerri Pottharst.

Dr Bright has licensed his methods to other practitioners around the country and because they use the patients' own cells he is not regulated by the Therapeutic Goods Administration (TGA).

Stem cells are often hailed as a miracle cure, but the nation's top stem cell scientists are warning that buyers should beware of these sorts of procedures, which are yet to be subjected to clinical trials.

Professor of Stem Cell Science at the University of Melbourne, Martin Pera, said almost all stem cell therapy was experimental.

"Actually, this whole science of cell therapy is relatively new and it's very, very important to understand that," he said.

Continue reading here:
Stem cell harvesting methods used by Sydney doctor Ralph Bright untested by clinical trials

Stem Cell Treatment for Multiple Sclerosis
http://msrelief.com According to Dr. Balshi, multiple sclerosis is not a stem cell disease so the stem cells are not affected by MS. Stem cells can be harvested from the fat, activated with...

By: Choose JOY MS Relief

View post:
Stem Cell Treatment for Multiple Sclerosis - Video

Best Eye Cream For Wrinkles based on the power of stem cells
http://thebesteyecreamforwrinkles.com/subscribe/ Best Eye Cream For Wrinkles based on the power of stem cells, so you can experience all the beauty of luminous eyes without dark circles wrinkle...

By: TheBestEyeCreamForWrinkles

See the rest here:
Best Eye Cream For Wrinkles based on the power of stem cells - Video

Stem Cell Testimonials Intro
A quick glimpse at what some of our patients experience with Beike #39;s adult stem cells at our partner treatment center Better Being Hospital! http://www.stemcelltreatmentnow.com http://www.betterbeingthailand.com.

By: Beike Biotech

Read the original here:
Stem Cell Testimonials Intro - Video